The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Murkamilov I.T.

Akhunbaev Kyrgyz State Medical Academy;
First President of Russia B.N. Yeltsin Kyrgyz Russian Slavic University

Aitbaev K.A.

Research Institute of Molecular Biology and Medicine

Fomin V.V.

Sechenov First Moscow State Medical University (Sechenov University)

Makhmudov I.S.

Republican Scientific Center of Emergency Medical Care

Solizhonov J.I.

Kazan State Medical University

Bashirov F.V.

Kazan State Medical University

Yusupov F.A.

Osh State University

Yusupova T.F.

Osh State University

Yusupova Z.F.

Osh State University

A case of ischemic stroke in a patient with probable CADASIL

Authors:

Murkamilov I.T., Aitbaev K.A., Fomin V.V., Makhmudov I.S., Solizhonov J.I., Bashirov F.V., Yusupov F.A., Yusupova T.F., Yusupova Z.F.

More about the authors

Read: 669 times


To cite this article:

Murkamilov IT, Aitbaev KA, Fomin VV, et al. . A case of ischemic stroke in a patient with probable CADASIL. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;124(12‑2):39‑45. (In Russ.)
https://doi.org/10.17116/jnevro202412412239

References:

  1. Adams HP Jr, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993;24(1):35-41.  https://doi.org/10.1161/01.str.24.1.35
  2. Miceli G, Basso MG, Rizzo G, et al. Artificial Intelligence in Acute Ischemic Stroke Subtypes According to Toast Classification: A Comprehensive Narrative Review. Biomedicines. 2023;11(4):1138. https://doi.org/10.3390/biomedicines11041138
  3. Ferrante EA, Cudrici CD, Boehm M. CADASIL: new advances in basic science and clinical perspectives. Curr Opin Hematol. 2019;26(3):193-198.  https://doi.org/10.1097/MOH.0000000000000497
  4. Markus HS. Diagnostic challenges in CADASIL. Arq Neuropsiquiatr. 2023;81(5):415-416.  https://doi.org/10.1055/s-0043-1769618
  5. Danchenko IIu, Kulesh AA, Drobakha VE, et al. CADASIL syndrome: differential diagnosis with multiple sclerosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2019;119(10-2):128-136. (In Russ.). https://doi.org/10.17116/jnevro201911910128
  6. Siva A. Common Clinical and Imaging Conditions Misdiagnosed as Multiple Sclerosis: A Current Approach to the Differential Diagnosis of Multiple Sclerosis. Neurol Clin. 2018;36(1):69-117.  https://doi.org/10.1016/j.ncl.2017.08.014
  7. Zhu S, Nahas SJ. CADASIL: Imaging Characteristics and Clinical Correlation. Curr Pain Headache Rep. 2016;20(10):57.  https://doi.org/10.1007/s11916-016-0584-6
  8. Yuan L, Chen X, Jankovic J, et al. CADASIL: A NOTCH3-associated cerebral small vessel disease. J Adv Res. 2024 Jan 2:S2090-1232(24)00001-8.  https://doi.org/10.1016/j.jare.2024.01.001
  9. Mizuta I, Nakao-Azuma Y, Yoshida H, et al. Progress to Clarify How NOTCH3 Mutations Lead to CADASIL, a Hereditary Cerebral Small Vessel Disease. Biomolecules. 2024;14(1):127.  https://doi.org/10.3390/biom14010127
  10. Wu S, Zhao N, Sun T, et al. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) with multiple different onset forms of frequent recurrent attacks: A case report and literature review. Medicine (Baltimore). 2024;103(11):e37563. https://doi.org/10.1097/MD.0000000000037563
  11. Romay MC, Knutsen RH, Ma F, et al. Age-related loss of Notch3 underlies brain vascular contractility deficiencies, glymphatic dysfunction, and neurodegeneration in mice. J Clin Invest. 2024;134(2):e166134. https://doi.org/10.1172/JCI166134
  12. Sukhonpanich N, Markus HS. Prevalence, clinical characteristics, and risk factors of intracerebral haemorrhage in CADASIL: a case series and systematic review. J Neurol. 2024;271(5):2423-2433. https://doi.org/10.1007/s00415-023-12177-0
  13. Jain S, Sirekulam V, Kinthada S, et al. Unveiling a Neurological Enigma: Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL) Presenting With Facial Palsy. Cureus. 2024;16(5):e60165. https://doi.org/10.7759/cureus.60165
  14. Şanli ZS, Anlaş Ö. Detecting a Novel NOTCH3 Variant in Patients with Suspected CADASIL: A Single Center Study. Mol Syndromol. 2024;15(2):89-95.  https://doi.org/10.1159/000534243
  15. Golubinskaya EP, Makalish TP, Kalfa MA, et al. Morphological and Molecular Genetic Diagnosis of CADASIL: a Rare Clinical Case. Journal of Clinical Practice. 2023;14(2):105-111. (In Russ.). https://doi.org/10.17816/clinpract121091
  16. Zhang X, Lee SJ, Young KZ, et al. Latent NOTCH3 epitopes unmasked in CADASIL and regulated by protein redox state. Brain Res. 2014;1583:230-236.  https://doi.org/10.1016/j.brainres.2014.08.018
  17. Lin C, Huang Z, Zhou R, et al. Notch3 and its CADASIL mutants differentially regulate cellular phenotypes. Exp Ther Med. 2021;21(2):117.  https://doi.org/10.3892/etm.2020.9549
  18. Kalaria RN, Low WC, Oakley AE, et al. CADASIL and genetics of cerebral ischaemia. J Neural Transm Suppl. 2002;(63):75-90.  https://doi.org/10.1007/978-3-7091-6137-1_5
  19. Elliott D. Migraine and stroke: current perspectives. Neurol Res. 2008;30(8):801-812.  https://doi.org/10.1179/174313208X341049
  20. Finsterer J. MELAS can be delineated from CADASIL by genotype and phenotype. Neurobiol Aging. 2021;103:128-129.  https://doi.org/10.1016/j.neurobiolaging.2020.10.021
  21. Anilkumar AC, Foris LA, Tadi P. Acute Disseminated Encephalomyelitis. 2024 Jan 26. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan. 
  22. Kazzi C, Alpitsis R, O’Brien TJ, et al. Cognitive and psychopathological outcomes in acute disseminated encephalomyelitis. BMJ Neurol Open. 2024;6(1):e000640. https://doi.org/10.1136/bmjno-2024-000640
  23. Chakraborty S, Narayan A, Chakraborty D, et al. Postdengue Acute Disseminated Encephalomyelitis. J Assoc Physicians India. 2024;72(6):94-96. 
  24. Co DO. Acquired Demyelinating Syndromes. Med Clin North Am. 2024;108(1):93-105.  https://doi.org/10.1016/j.mcna.2023.05.017
  25. Miller JB, Suchdev K, Jayaprakash N, et al. New Developments in Hypertensive Encephalopathy. Curr Hypertens Rep. 2018;20(2):13.  https://doi.org/10.1007/s11906-018-0813-y
  26. Siddiqi TJ, Usman MS, Rashid AM, et al. Clinical Outcomes in Hypertensive Emergency: A Systematic Review and Meta-Analysis. J Am Heart Assoc. 2023;12(14):e029355. https://doi.org/10.1161/JAHA.122.029355
  27. Donzuso G, Mostile G, Nicoletti A, et al. Basal ganglia calcifications (Fahr’s syndrome): related conditions and clinical features. Neurol Sci. 2019;40(11):2251-2263. https://doi.org/10.1007/s10072-019-03998-x
  28. Sánchez Sobrino P, Páramo Fernández C, Martínez Cueto P. Fahr’s syndrome. Rev Clin Esp (Barc). 2016;216(7):400-401. (English, Spanish). https://doi.org/10.1016/j.rce.2016.03.002
  29. Katwal S, Bhandari S, Ghimire A, et al. Fahr’s syndrome with hypoparathyroidism, thrombocytopenia, and seizure: a rare case report. Ann Med Surg (Lond). 2023;85(8):4131-4133. https://doi.org/10.1097/MS9.0000000000001032
  30. Belov BS. Progressive multifocal leukoencephalopathy: Rheumatological aspects. Sovremennaya Revmatologiya=Modern Rheumatology Journal. 2015;9(3):4-9. (In Russ.). https://doi.org/10.14412/1996-7012-2015-3-4-9
  31. Putilina MV, Ermoshkina NIu, Sigitov IS, et al. Progressive multifocal encephalopathy in neurological practice. S.S. Korsakov Journal of Neurology and Psychiatry. 2017;117(12):95-105. (In Russ.). https://doi.org/10.17116/jnevro201711712195-105
  32. Alves CAPF, Zandifar A, Peterson JT, et al. MELAS: Phenotype Classification into Classic-versus-Atypical Presentations. AJNR Am J Neuroradiol. 2023;44(5):602-610.  https://doi.org/10.3174/ajnr.A7837
  33. Hsu YR, Yogasundaram H, Parajuli N, et al. MELAS syndrome and cardiomyopathy: linking mitochondrial function to heart failure pathogenesis. Heart Fail Rev. 2016;21(1):103-116.  https://doi.org/10.1007/s10741-015-9524-5
  34. Casique L, De Lucca M, Mahfoud A, et al. MELAS a clinically and genetically heterogeneous syndrome. Clin Biochem. 2023;112:75-76.  https://doi.org/10.1016/j.clinbiochem.2022.11.007

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.